IDO1 and gastric neoplasm: Surprisingly, A922500 treatment also inhibited expression of NOX2 and indoleamine 2,3-dioxygenase (IDO) in MKN45 (Fig. 4d, e), two genes correlated with proliferation and migration of gastric tumor cells [15, 16].